LB2008: Evaluation of Knowledge and Practice About Prostate Cancer in Male Employees

Sponsor
Libbs Farmacêutica LTDA (Industry)
Overall Status
Completed
CT.gov ID
NCT05040672
Collaborator
(none)
280
1
13.9
20.1

Study Details

Study Description

Brief Summary

Analyze, through an online questionnaire, the knowledge and practice about the prevention and detection of prostate cancer in male employees of a pharmaceutical company.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: questionare online application

Detailed Description

In Brazil, there are still few published and current studies that explore man's attention and awareness of health. Historically, women attend medical appointments and perform routine tests more frequently than men. For this is very important Analyze, through an online questionnaire, the knowledge and practice about the prevention and detection of prostate cancer in male employees of Libbs Farmacêutica (a pharmaceutical company in Brazil).

Study Design

Study Type:
Observational
Actual Enrollment :
280 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of Knowledge and Practice About Prostate Cancer in Male Employees of Libbs Pharmaceuticals
Actual Study Start Date :
Jun 1, 2021
Actual Primary Completion Date :
Jul 29, 2022
Actual Study Completion Date :
Jul 29, 2022

Arms and Interventions

Arm Intervention/Treatment
Group I

All volunteer male employees of Libbs Pharmaceuticals residing in all Brazilian regions will participate in this research.An online questionnaire will be applied to assess research subjects understanding of prostate cancer and health habits.

Behavioral: questionare online application
questionare online application

Outcome Measures

Primary Outcome Measures

  1. Evaluation of Knowledge and Practice About Prostate Cancer e Healthy Habits [1 month]

    Assess the subjects knowledge and practice in relation to educational campaigns aimed at prostate cancer.All the information wil be collected using a questionnaire previously approved by the ethics committee.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male individuals included in the Libbs workforce;

  • Age 18 years or older;

  • Subjects who agree to participate in the study after reading and signing the Informed Consent Form.

Exclusion Criteria:
  • There is no exclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 Augusto Figueiredo São Paulo Brazil 01140050

Sponsors and Collaborators

  • Libbs Farmacêutica LTDA

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Libbs Farmacêutica LTDA
ClinicalTrials.gov Identifier:
NCT05040672
Other Study ID Numbers:
  • LB2008
First Posted:
Sep 10, 2021
Last Update Posted:
Aug 2, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 2, 2022